Skip to content
Home/Companies/MedTech/Fluoptics

Fluoptics

MedTech·France·Exited 2022·Held 12yr
Entry
2010
Hold
12yr
Exit
2022

Who owns Fluoptics?

Fluoptics is a French MedTech company, now owned by Getinge, which acquired it in 2022 from Angels Capital.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Angels Capital
Investor
Angels Capital
Angels Capital · 2008 · VC

Key facts

HQFrance
SectorMedTech
Exit Type
Trade Sale
Buyer
Getinge
Exit Year
2022

More from Angels Capital

Other portfolio companies in the same fund.

Citring
Citring
Active
ConsumerSpain· 2026
CoCircular
Active
ClimateTechSpain· 2026
IONLY
Ionly
Active
EnergySpain· 2026
Ola Creators
Active
HR TechSpain· 2026
TRAK
TRAK
Active
HealthTechSpain· 2026
Biotasmart
Active
HealthTechSpain· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Fluoptics?

Fluoptics is now owned by Getinge, which acquired it in 2022 from Angels Capital.

When did Getinge acquire Fluoptics?

Getinge acquired Fluoptics in 2022, buying from Angels Capital.

Who did Fluoptics sell to?

Angels Capital sold Fluoptics to Getinge in 2022 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue